Basel Medical Group (NASDAQ:BMGL) Stock Price Crosses Below Fifty Day Moving Average – Should You Sell?

Basel Medical Group Ltd (NASDAQ:BMGL)’s share price crossed below its fifty day moving average during trading on Tuesday. The stock has a fifty day moving average of $4.30 and traded as low as $1.53. Basel Medical Group shares last traded at $1.93, with a volume of 15,492,087 shares traded.

Basel Medical Group News Summary

Here are the key news stories impacting Basel Medical Group this week:

• Neutral Sentiment: BMGL trading was repeatedly paused under Limit Up-Limit Down (LULD) rules on November 10. The pauses indicate significant price volatility, but do not by themselves establish whether the move was positive or negative.
• Neutral Sentiment: A separate report listed zero shares short as of November 10, which conflicts with the reported October 30 short-interest figure; the figures may use different reporting dates or reflect a data discrepancy.
• Negative Sentiment: Short interest was reported at 107,869 shares as of October 30, up 731.6% from October 15, with 6.8% of shares sold short. This sharp rise suggests increased bearish bets, although the reported days-to-cover ratio was just 0.1 given high trading volume. Basel Medical Group Ltd Shares Shorted: Short Interest Up 731.6% in October

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the stock. Wall Street Zen upgraded shares of Basel Medical Group to a “hold” rating in a report on Saturday. Weiss Ratings raised shares of Basel Medical Group from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, November 4th. One research analyst has rated the stock with a Sell rating. According to MarketBeat.com, the stock currently has an average rating of “Sell”.

Basel Medical Group Stock Down 64.3%

The business has a 50 day simple moving average of $4.30 and a two-hundred day simple moving average of $6.34. The company has a current ratio of 1.23, a quick ratio of 1.21 and a debt-to-equity ratio of 0.75.

Basel Medical Group (NASDAQ:BMGL) last announced its earnings results on Friday, October 30th. The company reported ($0.31) earnings per share (EPS) for the quarter. The business had revenue of $3.14 million during the quarter.

Basel Medical Group Company Profile

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.